MedPath

Chlorhexidine

Generic Name
Chlorhexidine
Brand Names
Betasept, Hibiclens, Instillagel, Nupro Chlorhexidine, Oris, Oro-Clense, Paroex, Perichlor, Peridex, Periochip, Periogard, Prevora, X-pur
Drug Type
Small Molecule
Chemical Formula
C22H30Cl2N10
CAS Number
55-56-1
Unique Ingredient Identifier
R4KO0DY52L
Background

Chlorhexidine is a broad-spectrum antimicrobial biguanide used as a topical antiseptic and in dental practice for the treatment of inflammatory dental conditions caused by microorganisms. It is one of the most common skin and mucous membrane antiseptic agents in use today. The molecule itself is a cationic bis-guanide consisting of two 4-chlorophenyl rings and two biguanide groups joined by a central hexamethylene chain. Topical chlorhexidine for disinfection, as well as oral rinses for dental use, carries activity against a broad range of pathogens including bacteria, yeasts, and viruses.

Chlorhexidine was developed in the UK by Imperial Chemical Industries in the early 1950s and was introduced to the US in the 1970s. The FDA withdrew its approval for the use of chlorhexidine gluconate topical tincture 0.5%, due to a significant number of reports concerning chemical and thermal burns associated with the use of this product. Other formulations of chlorhexidine continue to be available.

Indication

Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures. Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis and a slow-release "chip" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.

Associated Conditions
Aphthous ulcer, Catarrh of the throat, Chemotherapy Induced Oral Mucositis, Chronic Wounds, Decubitus Ulcer, Dental Cavity, Dysphagia, Eczema infected, Foeter Ex Ore, Gingival Bleeding, Gingival Diseases, Gingivitis, Glossitis, Hoarseness, Infection, Infectious Periodontal Diseases, Injury Throat, Mild to Moderate Inflammatory Reaction of the Oral Cavity, Mild to Moderate Inflammatory Reaction of the Pharynx, Mouth injury, Mucositis, Neurodermatitis, Ocular Inflammation, Ocular Irritation, Oral Aphthous Ulcer, Pain, Periodontitis, Pharyngitis, Plaque, Dental, Postoperative Wound Infection, Purulent Gingivitis, Radiation Mucositis, Red eye, Ringworm, Skin Infections, Sore Throat, Stomatitis, Surgical Wounds, Tissue Damage, Tonsillitis, Ulcers, Leg, Wound Infections, Bacterial skin infections, Dry, cracked skin, Gum pain, Moderate Gingivitis, Oral infections, Oral lesions, Recurrent Oral fungal infection, Severe Gingivitis, Superficial Wounds, Throat disinfection, Tongue inflammation
Associated Therapies
Anesthesia of Mucous Membrane, Antimicrobial Therapy, Contact Lens Care, Disinfection, Disinfection of External Genitalia, Disinfection of the Urethra, Disinfection of the Vaginal Mucosa, Irrigation therapy, Lubrication of the Urethra, Oral Care, Oral Hygiene, Oropharyngeal antisepsis, Promotion of wound healing, Skin disinfection, Surgical Scrubbing, Topical Antisepsis, Urethral Anesthesia, Wound Cleansing, Oral antisepsis, Oral disinfection

Treatment of Periodontitis Stage II by Tulsi Gel

Phase 3
Not yet recruiting
Conditions
Periodontitis, Stage II
Interventions
First Posted Date
2024-11-05
Last Posted Date
2025-03-18
Lead Sponsor
Al-Azhar University
Target Recruit Count
24
Registration Number
NCT06675578
Locations
🇪🇬

Faculty of Dentistry, Al-Azhar university, Cairo, Egypt

Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries

Not Applicable
Recruiting
Conditions
Multidrug Resistant Bacterial Infection
Interventions
First Posted Date
2024-09-19
Last Posted Date
2025-02-20
Lead Sponsor
University of Pennsylvania
Target Recruit Count
270
Registration Number
NCT06590675
Locations
🇧🇼

Princess Marina Hospital, Gaborone, Botswana

Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Phase 4
Recruiting
Conditions
Urinary Tract Infections
Recurrent Urinary Tract Infection
Interventions
First Posted Date
2024-09-19
Last Posted Date
2025-03-24
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
136
Registration Number
NCT06598514
Locations
🇺🇸

Oregon Health & Science University, Portland, Oregon, United States

The Effect of Different Types of Mouthwash on Extraction Sockets' Healing

Phase 4
Not yet recruiting
Conditions
Extraction Socket Healing
Quality of Life
Postoperative Complications
Interventions
Drug: Bone Bioactive Liquid
Drug: Warm Saline Mouth Rinse
Drug: Hyaluronic Acid mouthwash
First Posted Date
2024-09-09
Last Posted Date
2024-09-09
Lead Sponsor
University of Jordan
Target Recruit Count
100
Registration Number
NCT06587880
Locations
🇯🇴

University of Jordan hospital, Amman, Jordan

Bacterial Decolonization Within Dyads

Not Applicable
Recruiting
Conditions
Bacterial Colonization
Interventions
First Posted Date
2024-08-07
Last Posted Date
2024-12-19
Lead Sponsor
Duke University
Target Recruit Count
20
Registration Number
NCT06541145
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

Comparison of the Effects of Oral Ulceration Healing in Patients Wearing a Removable Denture

Not Applicable
Completed
Conditions
Oral Mucosa; Ulcer
Interventions
First Posted Date
2024-08-01
Last Posted Date
2024-08-01
Lead Sponsor
Medical University of Silesia
Target Recruit Count
27
Registration Number
NCT06531720
Locations
🇵🇱

Department of TMD Silesian Medical University, Zabrze, Poland

The Effect of Oral Care on Mucositis and Oral Mucosa According to Individual Oral Care Frequency Assessment

First Posted Date
2024-07-25
Last Posted Date
2024-07-25
Lead Sponsor
TC Erciyes University
Target Recruit Count
41
Registration Number
NCT06521112
Locations
🇹🇷

Erciyes University, Kayseri, Turkey

Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT

Phase 1
Recruiting
Conditions
Periodontal Pocket
Interventions
First Posted Date
2024-07-17
Last Posted Date
2025-01-13
Lead Sponsor
Krishnadevaraya College of Dental Sciences & Hospital
Target Recruit Count
36
Registration Number
NCT06505759
Locations
🇮🇳

Dr. NALLAGATLA VAMSI VENKATA KRISHNA SAI, Bengaluru, Karnataka, India

Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement

Phase 3
Suspended
Conditions
Penile Prosthesis; Complications, Infection or Inflammation
Erectile Dysfunction
Interventions
First Posted Date
2024-07-05
Last Posted Date
2025-02-12
Lead Sponsor
Rush University Medical Center
Target Recruit Count
100
Registration Number
NCT06489431
Locations
🇺🇸

Rush University Medical Center, Chicago, Illinois, United States

🇺🇸

Uropartners Surgery Center, Des Plaines, Illinois, United States

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

Not Applicable
Recruiting
Conditions
Arthroplasty Shoulder
Periprosthetic Joint Infection
Interventions
First Posted Date
2024-06-18
Last Posted Date
2024-12-05
Lead Sponsor
University of Washington
Target Recruit Count
40
Registration Number
NCT06464770
Locations
🇺🇸

University of Washington, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath